Department of General Surgery, University of Ottawa, Ottawa, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Surg Endosc. 2018 Apr;32(4):1892-1900. doi: 10.1007/s00464-017-5881-6. Epub 2017 Oct 24.
Surgical resection remains a critical component of esophageal cancer treatment with curative-intent. The aim of this study was to compare open (OE) to minimally invasive Ivor Lewis esophagectomy (MIE) with respect to perioperative and oncologic outcomes.
Retrospective single-institution review of MIE and OE patients operated between 2001 and 2015 was conducted. Univariable and multivariable models were created using Cox regression. The Kaplan-Meier method was used to compare oncologic outcomes. Propensity score matching was used to compare oncological outcomes in MIE and OE patients.
Of 210 esophageal resection patients, 47% had OE (137/291) and 25% had MIE (73/291). The MIE and OE groups were comparable with respect to patient factors and operative details. Fewer OE patients received neoadjuvant chemoradiation. MIE was associated with improved lymph node yield, (MIE = 30 [IQR:22-39]; OE = 14 [IQR:7-19], p < 0.001), less intraoperative blood loss (MIE = 312 mL [100-400]; OE = 657 mL [350-700], p < 0.001), and shorter median length of stay (MIE = 10 days [IQR = 8-14]; OE = 14 days [IQR = 11-22] p < 0.01). The OE group had significantly more adverse events resulting in reoperation or intensive care unit admission (MIE = 21%; OE = 34%; p < 0.01). On multivariable analysis, age and positive resection margins were associated with decreased odds of survival. The number of lymph nodes retrieved, positive resection margins, and pathologic stage were significant predictors of disease-free survival. Analysis of 69 matched pairs showed equivalent median overall survival (MIE = 49 months [18-67]; OE = 29 months [17-69]; p = 0.26) and disease-free survival (MIE = 9 [6-22]; OE = 13 [6-22]; p = 0.45) between the two groups.
Although long-term oncologic outcomes appear to be similar, MIE is associated with significantly less intraoperative blood loss, improved lymph node yield, less risk of severe postoperative adverse events, and shorter length of stay.
手术切除仍然是具有治愈意图的食管癌治疗的关键组成部分。本研究旨在比较开放(OE)与微创 Ivor Lewis 食管切除术(MIE)在围手术期和肿瘤学结果方面的差异。
对 2001 年至 2015 年间接受 MIE 和 OE 治疗的患者进行回顾性单中心回顾。使用 Cox 回归建立单变量和多变量模型。使用 Kaplan-Meier 方法比较肿瘤学结果。使用倾向评分匹配比较 MIE 和 OE 患者的肿瘤学结果。
在 210 例食管切除术患者中,47%(137/291)接受了 OE,25%(73/291)接受了 MIE。MIE 和 OE 组在患者因素和手术细节方面具有可比性。较少的 OE 患者接受新辅助放化疗。MIE 与改善的淋巴结检出量相关(MIE=30 [IQR:22-39];OE=14 [IQR:7-19],p<0.001),术中出血量减少(MIE=312 毫升[100-400];OE=657 毫升[350-700],p<0.001),中位住院时间缩短(MIE=10 天[IQR:8-14];OE=14 天[IQR:11-22],p<0.01)。OE 组发生导致再次手术或入住重症监护病房的不良事件明显更多(MIE=21%;OE=34%;p<0.01)。多变量分析显示,年龄和阳性切缘与生存率降低相关。淋巴结检出数量、阳性切缘和病理分期是无病生存的显著预测因素。对 69 对匹配对的分析显示,两组的中位总生存(MIE=49 个月[18-67];OE=29 个月[17-69];p=0.26)和无病生存(MIE=9 个月[6-22];OE=13 个月[6-22];p=0.45)相似。
尽管长期肿瘤学结果似乎相似,但 MIE 与术中出血量显著减少、淋巴结检出量增加、术后严重不良事件风险降低和住院时间缩短相关。